NCT00066742View on ClinicalTrials.gov

Tirapazamine Combined With Chemo and RT in Limited-Stage Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions
Limited Stage Small Cell Lung Cancer
Interventions
DRUG

tirapazamine

Given IV

DRUG

cisplatin

Given IV

DRUG

etoposide

Given IV

RADIATION

radiation therapy

Undergo radiation therapy

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

78245

Southwest Oncology Group (SWOG) Research Base, San Antonio

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00066742 - Tirapazamine Combined With Chemo and RT in Limited-Stage Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter